Summary
The effects of a 10 day administration of clomipramine (25–50 mg t.i.d.), alprazolam (0.25–0.75 mg t.i.d.) and placebo were assessed in normal volunteers in a double-blind cross-over study. A battery of physiological, psychomotor and cognitive tests was administered both before and 3 h after drug on days 1, 5 and 10.
The effects of alprazolam on EEG and evoked potentials were characteristic of benzodiazepines; clomipramine had little effect. In contrast, reaction speed was markedly slowed by clomipramine but little affected by alprazolam.
Neither drug produced any accumulation of effect on a verbal recall task but neither did tolerance develop to the acute impairments produced by active treatments. Alprazolam produced an increase in levels of forgetting, especially on day 5. Subjective ratings for mood and bodily symptoms were adversely affected by clomipramine but little altered by alprazolam.
It is suggested that some of the differences between drug treatments may be due to differences in the speed of onset of tolerance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexander PE, Alexander DD (1986) Alprazolam treatment for panic disorders. J Clin Psychiatry 47: 301–304
Aranko K, Mattila MJ, Bordignon D (1985) Psychomotor effects of alprazolam and diazepam during acute and subacute treatment and during the follow-up phase. Acta Pharmacol Toxicol 56: 364–372
Baddeley AD, Sutherland A, Harris J (1982) How well do laboratory-based psychological tests predict patient's performance outside the laboratory? Aging 19: 141–148
Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP (1988) Alprazolam in panic disorders and agoraphobia: Results from a multicenter trial. 1. Efficacy in short-term treatment. Arch Gen Psychiatry 45: 413–422
Bättig WF, Montague WE (1969) Category norms for verbal items in 56 categories: A replication and extension of the Connecticut Category Norms. J Exp Psychol 80: 1–46
Block RI, Berchou R (1984) Alprazolam and lorazepam effects on memory acquisition and retrieval processes. Pharmacol Biochem Behav 20: 233–241
Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211–218
Bond A, Lader M, Shrotriya R (1983) Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG. Eur J Clin Pharm 24: 463–467
Branconnier RJ, Devitt DR, Cole JO, Spera KF (1982) Amitriptyline selectively disrupts verbal recall from secondary memory of the normal aged. Neurobiol Aging 3: 55–59
Burrows GD, Norman TR (1981) Tricyclic antidepressants: Plasma levels and clinical response. In: Burrows GD, Norman TR (eds) Psychotropic drugs: Plasma concentration and clinical response. Dekker, New York, pp 169–205
Chouinard G, Annable L, Fontaine R, Solyom L (1982) Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study. Psychopharmacology 77: 229–233
Ciraulo DA, Barnhill JG, Boxenham HG, Greenblatt DJ, Smith RB (1986) Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorders. J Clin Pharmacol 26: 292–298
Curran HV (1986) Tranquillizing memories: a review of the effects of benzodiazepines on human memory. Biol Psychol 23: 179–213
Curran HV, Sakulsripong M, Lader M (1988) Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles. Psychopharmacology 95: 520–527
Deutsch J (1971) The cholinergic synapse and the site of memory. Science 174: 788–794
Drachman DA (1978) Central cholinergic system and memory. In: Lipton LA, DiMascio A, Killam KF (eds) Psychopharmacology, A generation of progress. Raven. New York
Ghoneim MM, Mewaldt SP, Berie JL, Hinrichs JV (1981) Memory and performance effects of single and 3 week administration of diazepam. Psychopharmacology 73: 147–151
Gloger S, Grunhaus L, Birmacher B, Troudhart T (1981) Treatment of spontaneous panic attacks with chlomipramine. Am J Psychiatry 138: 1215–1217
Gloger S, Grunhaus L, Gladic D, O'Ryan F, Cohen L, Codner S (1989) Panic attacks and agoraphobia: Low dose clomipramine treatment. J Clin Psychopharm 9: 28–32
Greenblatt DJ, Divoll M, Abernathy DR, Moschitto LJ, Smith RB, Shader RI (1983) Alprazolam kinetics in the elderly. Arch Gen Psychiatry 40: 287–290
Greenblatt DJ, Harmatz JS, Dorsey C, Shader RI (1988) Comparative single dose kinetics and dynamics of lorazepam, alprazolam, prazepam and placebo. Clin Pharmacol Ther 44: 326–333
Kales A, Bixler EO, Vela-Bueno A, Soldatos CR, Manfredi RL (1987) Alprazolam: effects on sleep withdrawal phenomena. J Clin Pharmacol 27: 508–515
Lamping DL, Spring B, Gelenberg AJ (1984) Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study. Psychopharmacology 84: 254–261
Lydiard RB, Ballenger JC (1987) Antidepressants in panic disorders and agoraphobia. J Affective Disord 13: 153–168
McTavish D, Benfield P (1990) Clomipramine: An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 39: 136–153
Modigh K (1989) A treatment programme for panic disorder. In: Kielholz P, Adams C (eds) Panic anxiety states. Deutscher Ärzte-Verlag, Köln
Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD (1988) Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. II Patient acceptance, side effects and safety. Arch Gen Psychiatry 45: 423–428
Peck RE (1959) The SHP-test — an aid in the detection and measurement of depression. Arch Gen Psychiatry 1: 35–40
Pecknold JC, Swinson RP, Kuch K, Lewis CP (1988) Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. III Discontinuation effects. Arch Gen Psychiatry 45: 429–436
Roth T, Roehrs T, Wittig R, Zorick F (1984) Benzodiazepines and memory. Br J Clin Pharmacol 18: 45S-49S
Smith RB, Kroboth PD (1987) Influence of dosing regimes on alprazolam and metabolic serum concentrations and tolerance to sedative and psychomotor effects. Psychopharm 93: 105–112
Wechsler D (1955) Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allen, D., Curran, H.V. & Lader, M. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects. Eur J Clin Pharmacol 40, 355–362 (1991). https://doi.org/10.1007/BF00265843
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265843